BioChris joined Morgenthaler Ventures in 2001. Based in Boulder, Colorado, he is focusing on new biotechnology investments. Previously, he was the President and CEO of Ribozyme Pharmaceuticals, Inc., a Morgenthaler portfolio biotechnology company with a mission to commercialize the Nobel Prize-winning discovery of ribozymes for use as human therapeutics. He currently serves on seven corporate boards, and achieved succes ....
Education
Degrees
Start Free Trial
Access "Ralph E. (Chris)" Work Experience (Current/Past), Board Seats, Joined Date, Contact Details - Emailid/Phone and Investments (If any) in one connected platform (AcquityData).